741611
Last Update Posted: 2012-10-26
Recruiting has ended
All Genders accepted | 21 Years-75 Years |
44 Estimated Participants | No Expanded Access |
Interventional Study | Does not accept healthy volunteers |
Study of HD Mesh Ablation System for Treatment of Paroxysmal Atrial Fibrillation
This is a randomized controlled study of the Bard High Density Mesh Ablation System for treatment of paroxysmal atrial fibrillation. This study will determine if the HD Mesh Ablation System is as safe as and more effective than anti-arrhythmic drugs.
Eligibility
Relevant conditions:
Paroxysmal Atrial Fibrillation
If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the study if you think are close to fitting criteria.
locations
Data sourced from ClinicalTrials.gov